Antimicrobial Susceptibility Testing Market Size In 2026: Regional Growth, Key Segments And Future Outlook
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Antimicrobial Susceptibility Testing Market Value Growth And Long-Term Outlook
The antimicrobial susceptibility testing market has demonstrated significant expansion in recent years. This market is projected to expand from $4.65 billion in 2025 to $4.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. The growth observed in previous periods was primarily due to an increased occurrence of infectious diseases, heightened awareness regarding antimicrobial resistance, the enlargement of clinical microbiology laboratories, a rise in hospital diagnostic testing volumes, and the availability of standardized AST protocols.
The antimicrobial susceptibility testing market size is projected to experience substantial growth in the coming years. It is set to reach $6.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This expansion during the forecast period is driven by factors such as increased investments in rapid diagnostic technologies, the rising adoption of AI-assisted laboratory analysis, the broadening of surveillance programs for antimicrobial resistance, an escalating demand for point-of-care AST solutions, and a heightened emphasis on precision antimicrobial therapy. Key trends observed during this period encompass the increasing integration of automated AST systems, a rising need for rapid diagnostic testing, the expanding fusion of molecular and phenotypic methodologies, the widespread deployment of laboratory automation solutions, and an intensified focus on monitoring antimicrobial resistance.
Get A Free Sample Report With In-Depth Market Insights:
Antimicrobial Susceptibility Testing Market Growth Factors: What’s Supporting Expansion?
The worldwide increase in the occurrence of infectious diseases has significantly fueled the expansion of the antimicrobial susceptibility testing market. These illnesses are caused by organisms such as bacteria, viruses, fungi, and parasites. Examples of such conditions include bacterial pneumonia and tuberculosis, caused by bacteria, as well as viral diseases like smallpox and AIDS. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based national public health agency, reported that in 2023, among 9,573 TB cases in individuals whose birth origin was known, 7,259 (76%) were among non-U.S.–born persons. This represented an 18% increase when compared to the 6,177 similar cases recorded in 2022. Consequently, the rising incidence of infectious diseases is a major factor driving the growth of the antimicrobial susceptibility testing market.
Antimicrobial Susceptibility Testing Market Segment Analysis And Revenue Potential
The antimicrobial susceptibility testing market covered in this report is segmented –
1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types
2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems
2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods
4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing
Antimicrobial Susceptibility Testing Market Industry Trends: What’s Reshaping Demand?
Major companies operating in the antimicrobial susceptibility testing market are developing innovative products, such as the First POC Testing System. The First POC Testing System detects the presence or absence of bacteria and assesses the effectiveness of antimicrobials using urine samples from patients suspected of having urinary tract infections (UTIs). This represents a significant development in the field of AST technologies and helps to accelerate the initiation of targeted antimicrobial therapy for patients with infections. For instance, in June 2023, Sysmex Corporation, a Japan-based company that manufactures reagents and equipment for clinical tests, including hematologic (blood) and immune tests, launched a testing system for rapid detection of antimicrobial susceptibility. Using a unique and proprietary microfluidic technology, the system delivers antimicrobial susceptibility testing (AST) results in as little as 30 minutes from the start of measurement, a significant reduction compared to the several days required for conventional AST.
Antimicrobial Susceptibility Testing Market Key Players Shaping Industry Direction
Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S
View The Full Antimicrobial Susceptibility Testing Market Report:
Antimicrobial Susceptibility Testing Market Top Region By Revenue And Market Share
North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
